Using the experimental allergic encephalomyelitis (EAE) model of MS, Russi et al. discovered that testosterone prompts meningeal mast cells to secrete IL-33 in the males, therefore blocking the development of Th17 immune cells (112). The gene discussed is IL33; the disease is myeloid sarcoma.